![Statistics Consulting](https://amaris.com/wp-content/uploads/2020/08/Statistics.png)
[Home](https://amaris.com) | [Life Sciences](https://amaris.com/business-line/life-sciences/) | [Health Economics, Outcomes Research (HEOR) and Market Access](https://amaris.com/business-line/life-sciences/health-economics-outcomes-research-heor-and-market-access/)
# Statistics
**Getting key insights and statistics from clinical studies is critical to your product commercial strategy and reimbursement success. Individual Patient Data (IPD) analyses often hold the key to robust and differentiating economic evaluations and comparative effectiveness studies. Such research can provide necessary competitive advantage and support product positioning to payers as well as regulators. Individual Patient Data (IPD) analytics is an integral part of our outcomes research offering and a key competence within our department. Our team of biostatisticians can provide strategic and technical guidance as well as support in a flexible way to meet the needs of your product teams.**
At Amaris Consulting, we know that you invest a lot in your clinical trials. We care about your outcomes and are committed to ensuring you have the results you need to deliver more efficiently as we know that it will ultimately make you more competitive. We are proud to offer biostatistics services to our clients and partners. We are confident that we can help you make sense of your data because our department was founded on and grounded in robust quantitative methodology. Our team of biostatisticians can leverage our deep knowledge of various submission processes from different regions to support you in anticipating and planning for future challenges and advise you on the best ways to move forward.
## Amaris Consulting can support you with your statistical analyses across your productâ€™s development phases
  * Clinical trial data analyses
  * Subgroup analyses
  * Sensitivity analyses
  * HTA required analyses
  * Regulatory analyses
  * Coding quality check
  * Development of predictive algorithms


## Our experience spans a broad range of therapeutic areas
  * Hematology & Oncology
  * Respiratory
  * Immunology
  * Gastroenterology
  * Immuno-oncology
  * CVD/metabolics
  * Infectious diseases
  * Dermatology
  * Rare diseases
  * Neuroscience


## We support several different functions in your teams:
  * Health Economics and Outcome Research (HEOR)
  * Value and access
  * Medical affairs
  * R&D departments


## We believe that the following elements are our key success factors when performing biostatistics studies
  1. Multidisciplinary project teams working together to solve your research questions (clinicians, statisticians, epidemiologists, economists)
  2. Our rapid response unit ensures a fast turnover of data analyses following internal SOPs
  3. Our organizational structure is designed to ensure the highest quality of deliverables across offices
  4. We leverage our inner-group synergies to offer innovative solutions to you (i.e. using machine learning to compute large amounts of data)


Get in touch with us now to know our full spectrum of Life Sciences services, [Click Here](https://amaris.com/contact-us/)
[Back to Health Economics, Outcomes Research (HEOR) and Market Access Solutions](https://amaris.com/business-line/life-sciences/health-economics-outcomes-research-heor-and-market-access/)
![Amaris Logo](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%200%200'%3E%3C/svg%3E)
Amaris Consulting is your stepping stone to cross rivers of change, meet challenges, and achieve all your projects with success.
